Eray Eroğlu

768 total citations
58 papers, 520 citations indexed

About

Eray Eroğlu is a scholar working on Nephrology, Genetics and Surgery. According to data from OpenAlex, Eray Eroğlu has authored 58 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Nephrology, 17 papers in Genetics and 15 papers in Surgery. Recurrent topics in Eray Eroğlu's work include Genetic and Kidney Cyst Diseases (16 papers), Renal Diseases and Glomerulopathies (8 papers) and Dialysis and Renal Disease Management (8 papers). Eray Eroğlu is often cited by papers focused on Genetic and Kidney Cyst Diseases (16 papers), Renal Diseases and Glomerulopathies (8 papers) and Dialysis and Renal Disease Management (8 papers). Eray Eroğlu collaborates with scholars based in Türkiye, Sweden and Italy. Eray Eroğlu's co-authors include İsmail Koçyiğit, Bülent Tokgöz, Oktay Oymak, Murat Hayri Sipahioğlu, Bengt Lindholm, Aydın Ünal, Cengiz Utaş, Aydın Ünal, Gökmen Zararsız and Mahmut İlker Yılmaz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinica Chimica Acta and Nephrology Dialysis Transplantation.

In The Last Decade

Eray Eroğlu

57 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eray Eroğlu Türkiye 14 177 130 127 97 83 58 520
Robert E. Garola United States 15 188 1.1× 120 0.9× 163 1.3× 158 1.6× 154 1.9× 35 634
Guillaume Favrè France 14 164 0.9× 56 0.4× 122 1.0× 106 1.1× 130 1.6× 30 619
Jan L Walker Australia 10 91 0.5× 102 0.8× 152 1.2× 181 1.9× 192 2.3× 15 624
Deborah Kees‐Folts United States 10 224 1.3× 52 0.4× 174 1.4× 75 0.8× 118 1.4× 16 624
Alper Kırkpantur Türkiye 16 247 1.4× 55 0.4× 50 0.4× 112 1.2× 98 1.2× 34 583
Vincenzo Bisesti Italy 9 250 1.4× 84 0.6× 73 0.6× 125 1.3× 55 0.7× 14 498
Gad Kainer Australia 15 136 0.8× 58 0.4× 68 0.5× 78 0.8× 73 0.9× 41 520
Marios Papasotiriou Greece 13 218 1.2× 36 0.3× 102 0.8× 84 0.9× 136 1.6× 57 580
Séverine Beaudreuil France 13 190 1.1× 49 0.4× 89 0.7× 140 1.4× 109 1.3× 43 630
Markus Pirklbauer Austria 15 135 0.8× 30 0.2× 130 1.0× 88 0.9× 79 1.0× 33 462

Countries citing papers authored by Eray Eroğlu

Since Specialization
Citations

This map shows the geographic impact of Eray Eroğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eray Eroğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eray Eroğlu more than expected).

Fields of papers citing papers by Eray Eroğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eray Eroğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eray Eroğlu. The network helps show where Eray Eroğlu may publish in the future.

Co-authorship network of co-authors of Eray Eroğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Eray Eroğlu. A scholar is included among the top collaborators of Eray Eroğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eray Eroğlu. Eray Eroğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koçyiğit, İsmail, et al.. (2023). Elevated checkpoint inhibitor expression and Treg cell number in autosomal dominant polycystic kidney disease and their correlation with disease parameters and hypertension. Clinical and Experimental Medicine. 23(7). 3631–3640. 4 indexed citations
2.
Eroğlu, Eray, Çiğdem Karakükçü, Gökmen Zararsız, et al.. (2020). Hypoxia‐inducible factors in arteriovenous fistula maturation: A prospective cohort study. European Journal of Clinical Investigation. 50(12). e13350–e13350. 4 indexed citations
3.
Türkmen, Kültiğin, İsmail Koçyiğit, Orçun Altunören, et al.. (2020). The effect of Ramadan fasting on kidney function in patients with chronic kidney disease. International Urology and Nephrology. 52(7). 1337–1343. 10 indexed citations
4.
Eroğlu, Eray, İsmail Koçyiğit, & Bengt Lindholm. (2020). The endothelin system as target for therapeutic interventions in cardiovascular and renal disease. Clinica Chimica Acta. 506. 92–106. 38 indexed citations
5.
Koçyiğit, İsmail, Gökmen Zararsız, Eray Eroğlu, et al.. (2020). The effect of sodium exchange and dialytic biochemical parameters on blood pressure, arterial stiffness, and endothelial functions in patients with peritoneal dialysis. International Urology and Nephrology. 52(11). 2197–2203. 1 indexed citations
6.
Eroğlu, Eray, Aydın Ünal, Ahmet Tutuş, et al.. (2019). A Rare Reason of Kidney Failure in a Renal Transplant Recipient: Atrial Fibrillation. 2(2). 1–5. 1 indexed citations
7.
Zararsız, Gökmen, Serap Doğan, İsmail Koçyiğit, et al.. (2019). Autosomal dominant polycystic kidney disease: new role for ultrasound. European Radiology. 29(11). 5991–5998. 2 indexed citations
8.
Eroğlu, Eray, Murat Hayri Sipahioğlu, Soner Şenel, et al.. (2019). Successful treatment of tubulointerstitial nephritis in immunoglobulin G4-related disease with rituximab: A case report. World Journal of Clinical Cases. 7(16). 2309–2315. 3 indexed citations
9.
Eroğlu, Eray, Mustafa Çetın, Gökmen Zararsız, et al.. (2019). Multiple urinary tract infections are associated with genotype and phenotype in adult polycystic kidney disease. Clinical and Experimental Nephrology. 23(10). 1188–1195. 6 indexed citations
10.
Vural, Alperen, Mehmet İlhan Şahin, Eray Eroğlu, et al.. (2019). Mucociliary clearance in patients with continuous ambulatory peritoneal dialysis. Nefrología. 39(5). 545–551. 3 indexed citations
11.
Eroğlu, Eray, Züleyha Karaca, Mustafa Çetın, et al.. (2019). Dysmetabolic markers predict outcomes in autosomal dominant polycystic kidney disease. Clinical and Experimental Nephrology. 23(9). 1130–1140. 5 indexed citations
12.
Taşdemir, Zekeriya, et al.. (2018). The effect of periodontal disease treatment in patients with continuous ambulatory peritoneal dialysis. International Urology and Nephrology. 50(8). 1519–1528. 18 indexed citations
13.
Eroğlu, Eray, İsmail Koçyiğit, Aydın Ünal, et al.. (2017). Unicentric Castleman’s disease associated with end stage renal disease caused by amyloidosis. World Journal of Clinical Cases. 5(3). 119–119. 1 indexed citations
14.
Eroğlu, Eray, Hilmi Umut Ünal, Aydın Güçlü, et al.. (2017). The association of profilin‐1 levels with survival in chronic kidney disease. European Journal of Clinical Investigation. 47(12). 3 indexed citations
15.
Koçyiğit, İsmail, Serpil Taheri, Elif Funda Şener, et al.. (2017). Serum micro-rna profiles in patients with autosomal dominant polycystic kidney disease according to hypertension and renal function. BMC Nephrology. 18(1). 179–179. 24 indexed citations
16.
Koçyiğit, İsmail, Deniz Elçik, Eray Eroğlu, et al.. (2015). Association Between Cardiac Valvular Calcification and Serum Fetuin-A Levels in Renal Transplant Recipients. Transplantation Proceedings. 47(5). 1398–1401. 13 indexed citations
17.
Koçyiğit, İsmail, Eray Eroğlu, Aydın Ünal, et al.. (2014). Pentraxin 3 as a novel bio-marker of inflammation and endothelial dysfunction in autosomal dominant polycystic kidney disease. Journal of Nephrology. 27(2). 181–186. 19 indexed citations
18.
Koçyiğit, İsmail, Aydın Ünal, Ahmet Güney, et al.. (2013). Carpal Tunnel Release Surgery and Venous Hypertension in Early Hemodialysis Patients without Amyloid Deposits. The Scientific World JOURNAL. 2013(1). 481348–481348. 9 indexed citations
19.
Koçyiğit, İsmail, Murat Hayri Sipahioğlu, Aydın Ünal, et al.. (2012). Levofloxacin-Induced Delirium: Is It a Dangerous Drug in Patients with Renal Dysfunction?. Renal Failure. 34(5). 634–636. 15 indexed citations
20.
Koçyiğit, İsmail, Eray Eroğlu, Murat Hayri Sipahioğlu, et al.. (2012). Role of neutrophil/lymphocyte ratio in prediction of disease progression in patients with stage–4 chronic kidney disease. Journal of Nephrology. 26(2). 358–365. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert E. Garola Breakdown of academic impact, for papers by Guillaume Favrè Breakdown of academic impact, for papers by Jan L Walker Breakdown of academic impact, for papers by Deborah Kees‐Folts Breakdown of academic impact, for papers by Alper Kırkpantur Breakdown of academic impact, for papers by Vincenzo Bisesti Breakdown of academic impact, for papers by Gad Kainer Breakdown of academic impact, for papers by Marios Papasotiriou Breakdown of academic impact, for papers by Séverine Beaudreuil Breakdown of academic impact, for papers by Markus Pirklbauer
Rankless by CCL
2026